leisure time -WSS

leisure time

author：entertainment 2025-10-01 21:36:17 - browse：49

Scientific watchdogs Sholto David (right) and Elisabeth Bik join STAT's Jonathen Wosen at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.” The possibility that AI-generated, fraudulent data could be making its way into more established journals is a constant fear.

But institutions and academic journals aren’t doing enough about it, she said at the STAT breakthrough summit in San Francisco.

While artificial intelligence can be a powerful research tool when used legitimately, it’s also “absolutely frightening to me what AI can generate,” Bik said. “I’m worried this has already infiltrated scientific literature. It’s hard to tell [AI-generated images] apart from real photos. They look so real. I feel publishers are not putting [in] enough effort to deal with it — how do we find the fake photos?”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Ripples from Flovent's discontinuation is killing children with asthma

explore

WSS

Hospital price transparency does save money, advocate argues

Boston hospital trains restaurant workers on naloxone for overdoses

Abbott's new stent may help patients with peripheral artery disease

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

CEOs share strategies for surviving biotech slump

Lawmakers consider Medicare pay reforms for doctors

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Alkermes shareholders re

CEOs share strategies for surviving biotech slump

In Memoriam: Notable people who died in 2023

Galapagos to make CAR

Duchenne breakthrough therapy leaves behind pioneering families

STAT Summit: Biotech founders on deal

Sports medicine is finally prioritizing gender equality

Researchers explore possible ties between long Covid, menopause

Trump demands the U.S. pay no more for drugs than other countries … again

ALS treatment from Biogen, Ionis fails in study

hotspot

Hospital price transparency does save money, advocate argues

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

The EU Joint Clinical Assessment needs to live up to its promise

Solve the antibiotic resistance crisis with preventive drugs

WuXi Biologics execs register to lobby as Congress comes for the company

WuXi Biologics beefs up its lobbying operation

explore

hotspot

focus

Wikipedia